Business - Monitor   

Ranbaxy to receive royalty from Bayer

NEW DELHI: Ranbaxy Laboratories has said it will receive royalty on sales of Ciprofloxacin XR from Bayer with the latter commencing sales after receiving the U.S. Food and Drug Administration's approval. Bayer will begin shipping the products to U.S. pharmacies, a company release said. — PTI

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Entertainment | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• Indonesian police detain Polaris CEO
• Nasscom panel considers telecom bottlenecks
• Telco to launch Indigo
• Indian teraflop supercomputer ready
• Late profit taking pares early gains
• Rupee scales new peak
• NTPC to commission third 500 MW unit
• Bridgestone among 23 FDI approvals
• Stollberg to make India production hub
• Indirect tax: Advance Rulings for wholly owned foreign firms mooted
• NEG Micon commissions 9 MW wind farm
• Tiruchi consortium to retrieve lost IT ground
• `WTO regime serving developed nations'
• Stock Market Index
• Exchange rates
• Bullion rates
• Ranbaxy to receive royalty from Bayer
• Crisil upgrades Brakes India NCD rating
• India Intl. Products Expo 2002

Copyright © 2002, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu